|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-1-27
|
|
pubmed:abstractText |
Slow pathway (SP) ablation of AV nodal reentrant tachycardia (AVNRT) can be complicated by second- to third-degree AV block. We assessed the usefulness of pace mapping of Koch's triangle in preventing this complication.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1045-3873
|
|
pubmed:author |
pubmed-author:BonsoAldoA,
pubmed-author:Coro'LeonardoL,
pubmed-author:D'EsteDanieleD,
pubmed-author:DelisePietroP,
pubmed-author:FantinelMauroM,
pubmed-author:MantovanRobertoR,
pubmed-author:MarrasElenaE,
pubmed-author:SciarraLuigiL,
pubmed-author:SittaNadirN,
pubmed-author:VerlatoRobertoR,
pubmed-author:ZoppoFrancoF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
30-5
|
|
pubmed:meshHeading |
pubmed-meshheading:15673383-Cardiac Pacing, Artificial,
pubmed-meshheading:15673383-Catheter Ablation,
pubmed-meshheading:15673383-Electrocardiography,
pubmed-meshheading:15673383-Female,
pubmed-meshheading:15673383-Heart Block,
pubmed-meshheading:15673383-Humans,
pubmed-meshheading:15673383-Incidence,
pubmed-meshheading:15673383-Italy,
pubmed-meshheading:15673383-Male,
pubmed-meshheading:15673383-Middle Aged,
pubmed-meshheading:15673383-Prognosis,
pubmed-meshheading:15673383-Risk Assessment,
pubmed-meshheading:15673383-Risk Factors,
pubmed-meshheading:15673383-Surgery, Computer-Assisted,
pubmed-meshheading:15673383-Tachycardia, Atrioventricular Nodal Reentry
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Pace mapping of Koch's triangle reduces risk of atrioventricular block during ablation of atrioventricular nodal reentrant tachycardia.
|
|
pubmed:affiliation |
Operative Unit of Cardiology, Hospitals of Conegliano, Italy. pdelise@ulss7pieve.veneto.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|
